Best of ASCO - 2014 Annual Meeting

 

Welcome

Local-Regional Therapy

Breast Cancer—Local/Regional/Adjuvant

2019 ASCO Annual Meeting

Sort by: title abstract no. first author
ABSTRACT TITLEFIRST AUTHORABSTRACT NO.
“Good Risk”: low-risk patients with ductal carcinoma in situ (DCIS) benefit from whole breast radiotherapy after breast conservation surgery (BCS)–long-term follow-up.

Anna Niwinska

e12062

A prospective study to evaluate the accuracy of axillary staging using ultrasound and USG-guided fine needle aspiration cytology in early breast cancer patients in a high-volume center.

Rashpal Singh

e12060

A prospective validation cohort study of a prediction model on non-sentinel lymph node involvement in early breast cancer.

Xingfei Yu

559

Accelerated partial breast irradiation (APBI) using intensity modulated radiation therapy (IMRT) in stage 0-II breast cancer: A preliminary report of 57 cases.

Rufus J. Mark

e12068

Association between tumor biology and occult lymph node metastases before and after primary neoadjuvant therapy (NAT) for patients with early breast cancer.

Hans-Christian Kolberg

518

Automated artificial intelligence quantification of fibroglandular tissue on breast MRI.

Ruquaiyah Takhtawala

e12071

Breast cancer treatment according to pathogenic variants in cancer susceptibility genes in a population-based cohort.

Allison W. Kurian

560

Cctg MA.39 tailor RT: A randomized trial of regional radiotherapy in biomarker low-risk node-positive breast cancer (NCT03488693).

Wendy R. Parulekar

TPS602

Circulating tumor cells in patients with locally advanced breast cancer in evaluation of antitumor treatment efficacy.

Aleksandr B. Sagakyants

e12064

Clinical relevance of 21-gene recurrence score with lymph node involvement in HR+HER2- early breast cancer: A tumor size-match paired cohort study.

Xingfei Yu

e12059

Cognitive impairment in breast cancer patients before surgery?: Results of a subgroup of the French CANTO cohort.

Marie Lange

561

Comparing the American Joint Committee on Cancer (AJCC) breast cancer staging eighth versus seventh edition and breast cancer biology in large databases.

Jessica S. Young

e12077

Correlation analysis of radiotherapy and prognosis of elderly patients with hormone receptor-positive breast cancer in different immunohistochemical subtyping.

Jin Zhang

e12061

Correlation between TopIIα and ki-67 expression in tumors of luminal, primary operable breast cancer without HER2/neu overexpression in postmenopausal women as a prognostic factor.

Elena P. Ulianova

e12065

Does the innovative 4R Care Delivery Model improve timing and sequencing of guideline recommended breast cancer care in safety net and non-safety net centers?

Christine B. Weldon

562

Effectiveness of scalp cooling in reducing chemotherapy-induced alopecia: A single center prospective study in Lebanon.

Nour Haidar

e12075

Evaluation of immunotherapy (I-O)-associated immune cell (IC) dynamics and PD-L1 expression using multispectral immunohistochemistry (mIHC) and single-cell hierarchical regression modeling in early-stage breast cancer (ESBC).

Katherine Sanchez

e12070

Gene expression comparison between primary triple-negative breast cancer and matched axillary lymph node metastasis.

Marissa K. Srour

565

HIF1A genetic variability and late adverse events of radiotherapy in breast cancer.

Tanja Marinko

e12069

Impact of surgery type on survival in breast cancer patients.

Phuong Tuyet Ngo

e12072

Influence of radiation therapy on the outcome of T1-2N0M0 triple-negative breast cancer: A SEER population-based retrospective analysis.

Xiaoxiang Guan

e12073

KEYNOTE-756: Randomized, double-blind, phase 3 study of pembrolizumab vs placebo combined with neoadjuvant chemotherapy and adjuvant endocrine therapy for high-risk, early-stage estrogen receptor–positive, human epidermal growth factor receptor 2–negative (ER+/HER2−) breast cancer.

Fatima Cardoso

TPS601

No relationship of axillary total tumor load (TTL) by PCR (OSNA) in early breast cancer and local and distant clinical outcomes.

Jose Ales-Martinez

564

NRG Oncology/NSABP B-51/RTOG 1304: Phase III trial to determine if chest wall and regional nodal radiotherapy (CWRNRT) post mastectomy (Mx) or the addition of RNRT to whole breast RT post breast-conserving surgery (BCS) reduces invasive breast cancer recurrence-free interval (IBCR-FI) in patients (pts) with pathologically positive axillary (PPAx) nodes who are ypN0 after neoadjuvant chemotherapy (NC).

Eleftherios P. Mamounas

TPS600

Patient-reported outcomes (PROs) in NRG oncology/NSABP B-39/RTOG 0413: A randomized phase III study of conventional whole breast irradiation (WBI) versus partial breast irradiation (PBI) in stage 0, I, or II breast cancer.

Patricia A. Ganz

508

Prediction of occult axillary metastases in treatment-naïve patients with breast cancer: A transSENTINA analysis.

Cornelia Kolberg-Liedtke

566

Preoperative conventional axillary ultrasound (AUS) and sonoelastography (SE) for predicting axillary lymph node metastasis in breast cancer patients.

Alexander Petrovsky

e12074

Risk stratification in earl- stage luminal breast cancer patients treated with and without RT.

Charlotta Wadsten

568

Screening for cancer-related distress among women with newly diagnosed breast cancer (BC).

Lauren Z. Rynar

567

TARGIT E(lderly): Prospective phase II trial of intraoperative radiotherapy (IORT) in elderly patients with small breast cancer.

Frederik Wenz

563

The international collaboration of active surveillance trials for low-risk DCIS (LORIS, LORD, COMET, LORETTA).

Chizuko Kanbayashi

TPS603

Time to surgery and overall survival after breast cancer diagnosis in a universal health system.

Yvonne L Eaglehouse

e12063

Ultrasound-guided dual-localization for axillary nodes before and after neoadjuvant chemotherapy with clip and activated charcoal in breast cancer patients: A feasibility study.

Yee Soo Chae

e12067